| Literature DB >> 31553908 |
Audrey Paoletti1, Awatef Allouch1, Marina Caillet2, Hela Saïdi3, Frédéric Subra4, Roberta Nardacci5, Qiuji Wu1, Zeinaf Muradova1, Laurent Voisin1, Syed Qasim Raza1, Frédéric Law1, Maxime Thoreau1, Haithem Dakhli1, Olivier Delelis4, Béatrice Poirier-Beaudouin3, Nathalie Dereuddre-Bosquet6, Roger Le Grand6, Olivier Lambotte7, Asier Saez-Cirion8, Gianfranco Pancino8, David M Ojcius9, Eric Solary10, Eric Deutsch11, Mauro Piacentini12, Marie-Lise Gougeon3, Guido Kroemer13, Jean-Luc Perfettini14.
Abstract
Purinergic receptors and nucleotide-binding domain leucine-rich repeat containing (NLR) proteins have been shown to control viral infection. Here, we show that the NLR family member NLRP3 and the purinergic receptor P2Y2 constitutively interact and regulate susceptibility to HIV-1 infection. We found that NLRP3 acts as an inhibitory factor of viral entry that represses F-actin remodeling. The binding of the HIV-1 envelope to its host cell receptors (CD4, CXCR4, and/or CCR5) overcomes this restriction by stimulating P2Y2. Once activated, P2Y2 enhances its interaction with NLRP3 and stimulates the recruitment of the E3 ubiquitin ligase CBL to NLRP3, ultimately leading to NLRP3 degradation. NLRP3 degradation is permissive for PYK2 phosphorylation (PYK2Y402∗) and subsequent F-actin polymerization, which is required for the entry of HIV-1 into host cells. Taken together, our results uncover a mechanism by which HIV-1 overcomes NLRP3 restriction that appears essential for the accomplishment of the early steps of HIV-1 entry.Entities:
Keywords: CBL; HIV; NLRP3; P2Y2; inflammasome; viral entry
Year: 2019 PMID: 31553908 DOI: 10.1016/j.celrep.2019.02.095
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423